endo-BCN-PEG2-Val-Cit-PAB-MMAE
PG-20161-56026
Product information
- Catalog No.
- PG-20161-56026
- Product Name
- endo-BCN-PEG2-Val-Cit-PAB-MMAE
- CAS No.
- Not specified
- Molecular Formula
- C76H119N11O17
- Molecular Weight
- 1458.9
- Purity
- 98%
- Storage
- -20°C
- Shipping
- Ambient Temperature
- Documents
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
Packaging & pricing
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-56026 | 5 MG | Inquiry | In stock | |
| PG-20161-56026 | 10 MG | Inquiry | In stock | |
| PG-20161-56026 | 25 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
General Information
- Product Name
- endo-BCN-PEG2-Val-Cit-PAB-MMAE
- CAS No.
- Not specified
- Synonyms
- Not specified
- Molecular Formula
- C76H119N11O17
- Molecular Weight
- 1458.9
- Appearance
- Not specified
- Solubility
- Not specified
- Description
endo-BCN-PEG2-Val-Cit-PAB-MMAE is a synthetic linker-payload for use in constructing antibody drug conjugates (ADCs). It combines a chemically labile Val-Cit dipeptide with MMAE, a synthetic antineoplastic payload that can be attached to a monoclonal antibody. The BCN group reacts with azide-tagged compounds or biomolecules. Cataloged among cleavable ADC linkers and MMAE payloads, it has the molecular formula C76H119N11O17 and a listed purity of 98%.